NDC Package 67046-1417-3 Diltiazem Hydrochloride Extended Release

Capsule, Extended Release Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
67046-1417-3
Package Description:
30 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK
Product Code:
Proprietary Name:
Diltiazem Hydrochloride Extended Release
Non-Proprietary Name:
Diltiazem Hydrochloride
Substance Name:
Diltiazem Hydrochloride
Usage Information:
Diltiazem is contraindicated in:Patients with sick sinus syndrome except in the presence of a functioning ventricular pacemakerPatients with second- or third-degree AV block except in the presence of a functioning ventricular pacemakerPatients with severe hypotension (less than 90 mm Hg systolic)Patients who have demonstrated hypersensitivity to the drugPatients with acute myocardial infarction and pulmonary congestion documented by x-ray on admission.
11-Digit NDC Billing Format:
67046141703
NDC to RxNorm Crosswalk:
  • RxCUI: 830861 - dilTIAZem HCl 120 MG 24HR Extended Release Oral Capsule
  • RxCUI: 830861 - 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule
  • RxCUI: 830861 - diltiazem HCl 120 MG 24 HR Extended Release Oral Capsule
Product Type:
Human Prescription Drug
Labeler Name:
Coupler Llc
Dosage Form:
Capsule, Extended Release - A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form.
Administration Route(s):
Oral - Administration to or by way of the mouth.
Sample Package:
No
FDA Application Number:
NDA020401
Marketing Category:
NDA AUTHORIZED GENERIC - A product marketed as a "generic" drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),.
Start Marketing Date:
11-11-2024
Listing Expiration Date:
12-31-2025
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 67046-1417-3?

The NDC Packaged Code 67046-1417-3 is assigned to a package of 30 capsule, extended release in 1 blister pack of Diltiazem Hydrochloride Extended Release, a human prescription drug labeled by Coupler Llc. The product's dosage form is capsule, extended release and is administered via oral form.

Is NDC 67046-1417 included in the NDC Directory?

Yes, Diltiazem Hydrochloride Extended Release with product code 67046-1417 is active and included in the NDC Directory. The product was first marketed by Coupler Llc on November 11, 2024 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 67046-1417-3?

The 11-digit format is 67046141703. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-167046-1417-35-4-267046-1417-03